Opportunistic Infection

Active Projects: 15

Project Investigator All Topics Start date End date
University of California Global Health Institute Program for Fellows and Scholars Craig Cohen, MD, MPH Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Policy, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, International Health Policy, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training
Bartonella: dissecting niche-specific adaptation in a human pathogen Jane Koehler, MD Opportunistic Infection
The Connie Wofsy Women's HIV Study Ruth M. Greenblatt, MD HIV/AIDS, Opportunistic Infection, Women's Health
The Microbiome, Virome and Host Response in Ventilator Associated Pneumonia Joseph L. Derisi, PhD Infectious Disease, Opportunistic Infection
Evolution and Inhibition of Serine Beta-Lactamase Activity Adam R. Renslo, PhD Opportunistic Infection, Drug and Diagnostics Development
HIV/HPV cancer prevention treatment and pathogenesis: Rwanda /Einstein Consortium Joel Palefsky, MD HIV/AIDS, Opportunistic Infection, Cancer/Oncology
A Phase 3, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Oral Lefamulin (BC 3781) Versus Moxifloxacin in Adults With Community-Acquired Bacterial Pneumonia Steven R. Stoltz, MD Opportunistic Infection, Chronic Respiratory Disease
Uganda-UCSF Consortium on Prevention and Early Detection of HIV-associated Cancer Jeffrey N. Martin, MD, MPH HIV/AIDS, Opportunistic Infection, Cancer/Oncology
Gene circuits that control morphology in Histoplasma Anita Sil, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection
Epigenetic control of virulence in a fungal meningitis pathogen Hiten D. Madhani, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection
A Phase I, Dose Escalation Study To Establish Safety of Leukocyte Interleukin, Injection [Multikine] for Treatment of Perianal Condylomata In Adult Men and Women Who Are HIV/HPV Co-infected Joel Palefsky, MD HIV/AIDS, Opportunistic Infection, Cancer/Oncology
AIDS Malignancy Consortium (AMC) Lawrence D. Kaplan, MD HIV/AIDS, Opportunistic Infection, Cancer/Oncology
The transcriptional circuitry controlling biofilm development in Candida albicans Alexander D. Johnson, PhD Opportunistic Infection
ACTG: AIDS Clinical Trials Group Francesca T. Aweeka, PharmD HIV/AIDS, Opportunistic Infection
ACTG, AIDS Clinical Trial Research Group Diane V. Havlir, MD HIV/AIDS, Opportunistic Infection

Active Projects: 44

Project Investigator All Topics Start date End date
PCP OPW Specimens Laurence Huang, MD Opportunistic Infection
Phase III Study: Safety & Efficacy of Daptomycin Compared to Conventional Therapy in the Treatment of Subjects w/ infective endocarditis or bacteremia due to Staphylococcus aureus Henry Chambers, MD Opportunistic Infection
SMART Anal Dysplasia Sub-Study Joel Palefsky, MD HIV/AIDS, Opportunistic Infection, Cancer/Oncology
A Prophylactic Strategy Using Voriconazole vs. Inhaled Amphotericin to Prevent Invasive Aspergillosis in Lung Transplant Recipients Peter Chin-Hong, MD Infectious Disease, Opportunistic Infection, Chronic Respiratory Disease
International Randomized, Controlled Phase 3 Trial of DB289 Versus Trimethoprim-Sulfamethoxazole for Treatment of Acute Pneumocystis jiroveci Pneumnia (PCP) in Patients with HIV/AIDS Laurence Huang, MD HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
Deferasirox (Exjade)-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Peter Chin-Hong, MD Opportunistic Infection, Drug and Diagnostics Development
PCP OPW Specimens/Uganda Project Support Laurence Huang, MD Infectious Disease, HIV/AIDS, Opportunistic Infection
A Randomized, Double-Blind Study to Assess the Efficacy and Safety of Prophylactic Use of Maribavir Versus Oral Ganciclovir for the Prevention of Cytomegalovirus Disease in Recipients of Orthotopic Liver Transplants Peter Chin-Hong, MD Opportunistic Infection, Pharmacology and Drug Treatment
Protocol # ADMA-001: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Trial Evaluating the Safety and Efficacy of RI-001 in Medically Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Peter Chin-Hong, MD HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
Valley Fever Vaccine Project George W. Rutherford, MD Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection, Occupational and Environmental Disease, Drug and Diagnostics Development
Phase IV Open-Label, Non-comparative Trial of IV Anidulafungin followed by Oral Azole Therapy for the Treatment of Candidemia and Invasive Candidiasis Peter Chin-Hong, MD HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
A8851009: A Prospective, Randomized Trial Comparing the Efficacy of Anidulafungin and Voriconazole in Combination to that of Voriconazole Alone When Used For Primary Therapy of Proven or Probable Invasive Aspergillosis Peter Chin-Hong, MD Opportunistic Infection, Pharmacology and Drug Treatment
ADS-TCAD-P0206: TCAD Oral for Treatment of Influenza A Diane V. Havlir, MD Infectious Disease, HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
Task Order # 7: Supplement to SSS A5254 Diane V. Havlir, MD HIV/AIDS, Opportunistic Infection, Oral Health
Valley Fever Vaccine Project 2010 George W. Rutherford, MD Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection, Occupational and Environmental Disease, Drug and Diagnostics Development
Rifabutin Based Therapy for Eradication of Staph Carriage in HIV-Infected Individuals with Prior Skin Structure Infections Henry Chambers, MD HIV/AIDS, Opportunistic Infection
Diagnosis, Prevention, and Management of Cryptococcus Infection (Meningeal and Non-Meningeal) George W. Rutherford, MD Infectious Disease, HIV/AIDS, Opportunistic Infection
Natural History and Outcomes of Coccidioidomycosis Retrospective Record Review Study Peter Chin-Hong, MD Infectious Disease, Opportunistic Infection, Systematic Reviews and Guideline Development
Efficacy and Safety of Eraxis/Ecalta (Anidulafungin) Compared to Cancidas (Caspofungin) in Patients with Candida Deep Tissue Infection: A Phase 4 Study Peter Chin-Hong, MD Infectious Disease, HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
WSA-CS-003: Open Label Study of Isavuconazole in the Treatment of Patients with Aspergillosis and Renal Impairment or of Patients with Invasive Fungal Disease Caused by Rare Molds, Yeasts or Dimorphic Fungi Peter Chin-Hong, MD Infectious Disease, Opportunistic Infection, Pharmacology and Drug Treatment
AIDS Clinical Trial Research Group (ACTG), Studies: A5306, A5254, A5298 Diane V. Havlir, MD HIV/AIDS, Opportunistic Infection, Tuberculosis, Oral Health
Effects of Traffic Pollution on Lung Immunity and Pneumonia in Persons with HIV Robert J. Blount, MD HIV/AIDS, Opportunistic Infection
Targeted Treatment of Early Cryptococcal Infection in HIV-infected Patients Mark A. Jacobson, MD HIV/AIDS, Opportunistic Infection
Host-pathogen Interactions during Vertical Transmission of Listeria monocytogenes Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection, Women's Health, Labor and Delivery, Newborn and Infant Health
Gene Circuits that Control Morphology in Histoplasma Anita Sil, MD, PhD Infectious Disease, Opportunistic Infection
AIDS Education and Training Center (AETC) National Resource Center / Website Susan C. Coffey, MD HIV/AIDS, Opportunistic Infection, Training and Capacity Building, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education, Patient and Peer Education
UCB-UCSF-MU Research Training on Tuberculosis (TB) and Other Pulmonary Complications of HIV J. Luke Davis, MD HIV/AIDS, Opportunistic Infection, Tuberculosis, Chronic Respiratory Disease, Health Systems Strengthening, Training and Capacity Building, Training International Scholars and Clinicians
Phase III Study to Evaluate the Safety and Efficacy of BAL8557 Versus a Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections Peter Chin-Hong, MD Opportunistic Infection
Viral Pathogen Discovery in Opportunistic Infections in the Post-Transplant Setting Peter Chin-Hong, MD Infectious Disease, Opportunistic Infection, Surgery and Anesthesia
A Clinical Trial for Uncomplicated Skin Infections in Areas of Epidemic Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Henry Chambers, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection
Regulatory Circuits That Link Cell Fate and Virulence in Histoplasma Capsulatum Sinem Beyhan-Pelvan, PhD Opportunistic Infection
Multi-Locus Sequence Typing Environmental Fungal Samples from Western Kenya Kristyn E. Feldman, PhD Opportunistic Infection, Occupational and Environmental Disease
Pathogenesis of HIV-Related Bacillary Angiomatosis Jane Koehler, MD Infectious Disease, HIV/AIDS, Opportunistic Infection, Cancer/Oncology
UCSF Cutaneous Immunology Core: OSM Project Opportunistic Infection, Cancer/Oncology, Immunology
Regulation of Virulence of Cryptococcus neoformans Hiten D. Madhani, MD, PhD HIV/AIDS, Opportunistic Infection
A Multicenter, Multinational, Retrospective Review of Voriconazole Experience for the Prophylaxis against Invasive Aspergillosis in Lung Transplant Recipients Peter Chin-Hong, MD Opportunistic Infection, Chronic Respiratory Disease
Proteomics Analysis of Host-Pathogen Interactions in Histoplasma Anita Sil, MD, PhD Opportunistic Infection, Immunology
Evolution of transcription circuits driving biofilm formation in Candida species Eugenio Mancera Ramos, PhD Opportunistic Infection
Microbiome, Virome, and Host Responses Preceding Ventilator-Associated Pneumonia (VAP) Anil Sapru, MD Opportunistic Infection, Occupational and Environmental Disease, Pediatrics
Comparative Effectiveness of Antiretroviral Therapy (ART) with Upfront Chemotherapy versus ART Alone in HIV-Infected Patients with Kaposi Sarcoma without Urgent Indications for Chemotherapy HIV/AIDS, Opportunistic Infection, Cancer/Oncology, Pharmacology and Drug Treatment
HPV testing of samples from the AIDS Malignancy Consortium Joel Palefsky, MD HIV/AIDS, Opportunistic Infection, Cancer/Oncology
Regulation of Virulence of Cryptococcus neoformans Hiten D. Madhani, MD, PhD Opportunistic Infection
Regulatory circuits and virulence in candida albicans Alexander D. Johnson, PhD Opportunistic Infection
Transcriptional rewiring of aging pathways and dietary restriction effects in yeasts Alexander D. Johnson, PhD Opportunistic Infection